Transporting pharmacogenomics into clinical practice.
Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, United States. Electronic address: scott.friedman@mssm.edu.
Scott L
SL
Friedman
D000818:Animals; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics*; D027381:Liver-Specific Organic Anion Transporter 1; D008297:Male; D029362:Organic Anion Transporters, Sodium-Independent / Q000172:deficiency* / Q000235:genetics*; D017035:Pravastatin / Q000493:pharmacokinetics*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D027381:Liver-Specific Organic Anion Transporter 1; D029362:Organic Anion Transporters, Sodium-Independent; C498887:Slco1b2 protein, mouse; D017035:Pravastatin